黄芪注射液联合丹参注射液治疗急性脑梗塞56例

Astragalus Injection Combined Salvia Injection on Acute Cerebral Infarction 56 Cases

[目的]探讨黄芪注射液联合丹参注射液治疗急性脑梗塞的临床疗效。[方法]将发病72h以内的急性脑梗塞患者随机分为两组。治疗组56例采用黄芪注射液联合丹参注射液静滴,对照组56例采用丹参注射液静滴。两组其他治疗相同。观察两组疗效及神经功能缺损评分和日常生活活动量表评分。[结果]总有效率治疗组为92.8%,对照组为83.9%,两组总有效率比较,差异有显著性意义(P<0.05)。治疗后治疗组神经功能缺损程度评分改善及日常生活活动能力量表评分均优于对照组。[结论]黄芪注射液联合丹参注射液治疗急性脑梗塞疗效可靠,安全性好。

[ Objective] Astragalus injection combined salvia injection on acute cerebral infarction with clinical efficacy. [Methods] Within 72 hours of onset of acute cerebral infarction were randomly divided into two groups. 56 cases treated group injection joint salvia intravenous injection, the control group, 56 cases of intravenous infusion of Danshen injection. Two other treatment groups the same. Observation 2 group efficacy and neurological deficit score and activities of daily living scale score. [ Results ] The total effective treatment group was 92.8%, control group was 83.9% , total effective rate, the difference was significant （P 〈0.05）. After treatment, neurological deficits and activities of daily living score improved scale scores were better than the control group. [ Conclusion]AI joint salvia injection on acute cerebral infarction reliable, safe and good.